Literature DB >> 14528051

Tau protein in familial and sporadic diseases.

Despina Yancopoulou1, Maria Grazia Spillantini.   

Abstract

Abnormal protein aggregation is a common characteristic of many neurodegenerative diseases of the brain. Filamentous deposits made of the microtubule-associated protein tau constitute a major defining characteristic of several neurodegenerative diseases known as tauopathies. The role of tau in neurodegeneration has been clarified by the identification of genetic mutations in the tau gene in cases with familial frontotemporal dementia and parkinsonism linked to chromosome 17. Furthermore, some sporadic tauopathies are associated with tau gene polymorphisms. Although it is still debated how tau gene mutations lead to neuronal death, it is clear that different mutations lead to tau pathologies with characteristics similar to those found in sporadic tauopathies. These findings have definitely shown that in tauopathies tau aggregation is directly associated with development of neurodegeneration and neuronal death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14528051     DOI: 10.1385/NMM:4:1-2:37

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   4.103


  101 in total

1.  The microtubule associated protein Tau gene and Alzheimer's disease--an association study and meta-analysis.

Authors:  C Russ; J F Powell; J Zhao; M Baker; M Hutton; F Crawford; M Mullan; G Roks; M Cruts; S Lovestone
Journal:  Neurosci Lett       Date:  2001-11-13       Impact factor: 3.046

2.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

3.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

4.  Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.

Authors:  Bridget Allen; Esther Ingram; Masaki Takao; Michael J Smith; Ross Jakes; Kanwar Virdee; Hirotaka Yoshida; Max Holzer; Molly Craxton; Piers C Emson; Cristiana Atzori; Antonio Migheli; R Anthony Crowther; Bernardino Ghetti; Maria Grazia Spillantini; Michel Goedert
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

5.  Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

Authors:  P M Stanford; G M Halliday; W S Brooks; J B Kwok; C E Storey; H Creasey; J G Morris; M J Fulham; P R Schofield
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

6.  5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.

Authors:  A Grover; H Houlden; M Baker; J Adamson; J Lewis; G Prihar; S Pickering-Brown; K Duff; M Hutton
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

7.  Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders.

Authors:  P K Panegyres; K Zafiris-Toufexis
Journal:  Eur J Neurol       Date:  2002-09       Impact factor: 6.089

8.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure.

Authors:  John Berriman; Louise C Serpell; Keith A Oberg; Anthony L Fink; Michel Goedert; R Anthony Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

9.  Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium.

Authors:  P Bennett; V Bonifati; U Bonuccelli; C Colosimo; M De Mari; G Fabbrini; R Marconi; G Meco; D J Nicholl; F Stocchi; N Vanacore; P Vieregge; A C Williams
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

10.  Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease.

Authors:  A Ebneth; R Godemann; K Stamer; S Illenberger; B Trinczek; E Mandelkow
Journal:  J Cell Biol       Date:  1998-11-02       Impact factor: 10.539

View more
  14 in total

1.  Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population.

Authors:  Zhihong Shi; Shuai Liu; Lei Xiang; Ying Wang; Mengyuan Liu; Shuling Liu; Tong Han; Yuying Zhou; Jinhuan Wang; Li Cai; Shuo Gao; Yong Ji
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

Review 2.  Frontotemporal lobar degeneration: current knowledge and future challenges.

Authors:  Chiara Cerami; Elio Scarpini; Stefano F Cappa; Daniela Galimberti
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

3.  Neuronal degeneration, synaptic defects, and behavioral abnormalities in tau₄₅₋₂₃₀ transgenic mice.

Authors:  A E Lang; D N Riherd Methner; A Ferreira
Journal:  Neuroscience       Date:  2014-06-18       Impact factor: 3.590

4.  Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies.

Authors:  Adriana Ferreira; Eileen H Bigio
Journal:  Mol Med       Date:  2011-03-21       Impact factor: 6.354

Review 5.  Clinical phenotypes and genetic biomarkers of FTLD.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  J Neural Transm (Vienna)       Date:  2012-04-19       Impact factor: 3.575

Review 6.  Tau and tauopathies.

Authors:  Gloria Lee; Chad J Leugers
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

7.  Morin attenuates tau hyperphosphorylation by inhibiting GSK3β.

Authors:  Eun Ji Gong; Hee Ra Park; Mi Eun Kim; Shunfu Piao; Eunjin Lee; Dong-Gyu Jo; Hae Young Chung; Nam-Chul Ha; Mark P Mattson; Jaewon Lee
Journal:  Neurobiol Dis       Date:  2011-07-18       Impact factor: 5.996

8.  Neuronal hypertrophy in asymptomatic Alzheimer disease.

Authors:  Diego Iacono; Richard O'Brien; Susan M Resnick; Alan B Zonderman; Olga Pletnikova; Gay Rudow; Yang An; Mark J West; Barbara Crain; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

9.  Interaction of tau protein with the dynactin complex.

Authors:  Enrico Magnani; Juan Fan; Laura Gasparini; Matthew Golding; Meredith Williams; Giampietro Schiavo; Michel Goedert; Linda A Amos; Maria Grazia Spillantini
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

10.  Mice with mutation in dynein heavy chain 1 do not share the same tau expression pattern with mice with SOD1-related motor neuron disease.

Authors:  Magdalena Kuźma-Kozakiewicz; Ewa Usarek; Albert C Ludolph; Anna Barańczyk-Kuźma
Journal:  Neurochem Res       Date:  2011-03-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.